Plasma betacarotene in Alzheimer's disease.: Association with cerebrospinaffluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau

被引：0

作者：

Stuerenburg, HJ ^{[1
]}

Ganzer, S

Müller-Thomsen, T

机构：

[1] Median Klin Bad Suelze, Dept Neurol, D-18334 Bad Suelze, Germany

[2] Univ Hosp Hamburg Eppendorf, Clin Psychiat & Psychotherapy, Hamburg, Germany

[3] Psychiat Clin Haecklingen, Lueneburg Uelzen, Germany

来源：

NEUROENDOCRINOLOGY LETTERS | 2005年 / 26卷 / 06期

关键词：

plasma betacarotene; Alzheimer's disease; cerebrospinal fluid; beta-amyloid; 1-42; 1-40; total Tau; MMSE; anti-amyloidogenic; diet;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We studied the plasma betacarotene concentrations in 40 Alzheimer's disease patients and the association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), cerebrospinal fluid beta-amyloid 1-42 (Abeta42) and cerebrospinal fluid total Tau. We found that patients with plasma beta carotene levels below the 25th percentile had 55% reduced ratios of Abeta40/Tau and 51% reduced ratios of Abeta 40/Abeta 42 compared with patients in the highest quartile. Mean Tau concentrations in the lowest quartile of plasma beta-carotene levels were 74% higher compared with the highest quartile of plasma beta-carotene levels. Thus, we could demonstrate an statistically significant association between beta carotene levels in plasma and neurochemical markers in the cerebrospinal fluid of Alzheimer's disease patients.

引用

页码：696 / 698

页数：3

共 50 条

[1] Interaction of beta-amyloid 1-42 (Abeta-1-42) with synaptosomal proteins as well as pentapeptide derived from Abeta 1-42
Penke, B
Szegedi, V
Datki, Z
Verdier, Y
Fülöp, L
Penke, Z
Soós, K
Zarándi, M
FEBS JOURNAL, 2005, 272 : 536 - 536
[2] Amyloid beta protein 1-38 (Abeta 38), Abeta 40 and Abeta42 levels in matched CSF and plasma in Alzheimer disease (AD)
Mehta, PD
Pirttila, T
FASEB JOURNAL, 2005, 19 (04): : A967 - A967
[3] Gel electrophoretic distinction between Congo Red nonreactive beta-amyloid (1-42) and beta-amyloid (1-40)
Chrambach, A
Chrambach, A
Brining, SK
ELECTROPHORESIS, 2000, 21 (04) : 760 - 761
[4] EFFECT OF CHOLESTEROL ON THE DEPOSITION OF BETA-AMYLOID 1-40 AND 1-42 FILMS
Breazu, C.
Stanculescu, A.
Socol, M.
Rasoga, O.
DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES, 2015, 10 (01) : 299 - 313
[5] CSF Abeta38, Abeta40 and Abeta42 levels in Alzheimer's disease patients and controls
Schoonenboom, NS
Scheltens, P
Van Kamp, GJ
Mehta, PD
NEUROBIOLOGY OF AGING, 2004, 25 : S147 - S147
[6] Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease
Thijssen, Elisabeth H.
Verberk, Inge M. W.
Vanbrabant, Jeroen
Koelewijn, Anne
Heijst, Hans
Scheltens, Philip
van der Flier, Wiesje
Vanderstichele, Hugo
Stoops, Erik
Teunissen, Charlotte E.
SCIENTIFIC REPORTS, 2021, 11 (01)
[7] Activation of neuronal cortical network activation through beta-amyloid (Abeta 1-42) on the neurochip
Lange-Asschenfeldt, Christian
Goertz, P.
Hermes, M.
Hamacher, N.
Siebler, M.
NERVENARZT, 2007, 78 : 139 - 139
[8] Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43
Wiltfang, J
Smirnov, A
Schnierstein, B
Kelemen, G
Matthies, U
Klafki, HW
Staufenbiel, M
Huther, G
Ruther, E
Kornhuber, J
ELECTROPHORESIS, 1997, 18 (3-4) : 527 - 532
[9] Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment
Pesaresi, Marzia
Lovati, Carlo
Bertora, Pierluigi
Mailland, Enrico
Galimberti, Daniela
Scarpini, Elio
Quadri, Pierluigi
Forloni, Gianluigi
Mariani, Claudio
NEUROBIOLOGY OF AGING, 2006, 27 (06) : 904 - 905
[10] Study of beta-amyloid peptide (Abeta40) insertion into phospholipid membranes using monolayer technique
Ji, S.
Wu, Y.
Sui, S.
Biokhimiya, 2002, 67 (11): : 1553 - 1560

← 1 2 3 4 5 →